Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Alpine Immune Sciences, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −2 vs. Q2 2021
- Shares held
- 15.3M
- +2.17M (+16.5%) vs. Q2 2021
- Total value
- $163.5M
- +$45.1M (+38.1%) vs. Q2 2021
- New holders
- 4
- 18 more added
- Sold out
- 6
- 13 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 180 | $2.56B |
| Q4 2023 | 133 | $1.12B |
| Q3 2023 | 88 | $525.8M |
| Q2 2023 | 77 | $449.3M |
| Q1 2023 | 61 | $319.4M |
| Q4 2022 | 64 | $300.8M |
| Q3 2022 | 70 | $284.0M |
| Q2 2022 | 58 | $204.4M |
| Q1 2022 | 56 | $221.8M |
| Q4 2021 | 53 | $257.1M |
| Q3 2021 | 44 | $163.5M |
| Q2 2021 | 47 | $118.5M |
| Q1 2021 | 48 | $145.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Alpine Immune Sciences, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 911 | $10.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,183 | $12.0K | 0.00% | +388+48.8% | Added |
| UBS Group AG | 1,142 | $12.0K | 0.00% | +1,142 | New |
| Legal & General Group Plc | 1,227 | $13.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,326 | $14.0K | 0.00% | +774+140.2% | Added |
| Tower Research Capital LLC (TRC) | 1,988 | $21.0K | 0.00% | +1,274+178.4% | Added |
| BNP Paribas Arbitrage, SA | 2,116 | $22.6K | 0.00% | +1,668+372.3% | Added |
| Morgan Stanley | 2,734 | $28.0K | 0.00% | −592−17.8% | Reduced |
| Bank of America Corp | 3,371 | $36.0K | 0.00% | +1,145+51.4% | Added |
| JPMorgan Chase & Co | 4,460 | $48.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 4,747 | $51.0K | 0.00% | +3,278+223.1% | Added |
| New York State Common Retirement Fund | 5,417 | $58.0K | 0.00% | −4,883−47.4% | Reduced |
| California State Teachers Retirement System | 6,215 | $66.0K | 0.00% | −9,922−61.5% | Reduced |
| American International Group, Inc. | 6,358 | $68.0K | 0.00% | −151−2.3% | Reduced |
| Deutsche Bank AG | 6,680 | $71.0K | 0.00% | −127,377−95.0% | Reduced |
| EcoR1 Capital, LLC | 7,001 | $75.0K | 0.00% | −515,634−98.7% | Reduced |
| Hikari Power Ltd | 10,445 | $111.0K | 0.01% | 00.0% | Unchanged |
| HighVista Strategies LLC | 14,268 | $152.0K | 0.10% | +14,268 | New |
| Leonard Rickey Investment Advisors P.L.L.C. | 17,013 | $182.0K | 0.08% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 18,446 | $184.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 24,623 | $263.0K | 0.00% | −4,137−14.4% | Reduced |
| Alps Advisors Inc | 29,304 | $313.0K | 0.00% | −2,194−7.0% | Reduced |
| Two Sigma Investments, LP | 39,218 | $418.0K | 0.00% | +22,304+131.9% | Added |
| Two Sigma Advisers, LP | 41,675 | $445.0K | 0.00% | −27,500−39.8% | Reduced |
| Dimensional Fund Advisors LP | 50,364 | $538.0K | 0.00% | +5,064+11.2% | Added |
| Bank of New York Mellon Corp | 50,538 | $539.0K | 0.00% | +8,676+20.7% | Added |
| Wells Fargo & Company | 54,878 | $585.0K | 0.00% | +54,578+18,192.7% | Added |
| Ensign Peak Advisors, Inc | 72,930 | $778.0K | 0.00% | +18,350+33.6% | Added |
| Northern Trust Corp | 107,234 | $1.14M | 0.00% | −6,345−5.6% | Reduced |
| DAFNA Capital Management LLC | 111,501 | $1.19M | 0.32% | −1,801−1.6% | Reduced |
| Tiger Management L.L.C. | 137,728 | $1.47M | 0.27% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 153,611 | $1.64M | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 194,021 | $2.07M | 0.00% | +2,483+1.3% | Added |
| State Street Corp | 197,796 | $2.11M | 0.00% | +24,677+14.3% | Added |
| Renaissance Technologies LLC | 395,594 | $4.22M | 0.01% | −3,400−0.9% | Reduced |
| Logos Global Management LP | 425,000 | $4.54M | 0.33% | +425,000 | New |
| BlackRock Inc. | 547,782 | $5.84M | 0.00% | +3,627+0.7% | Added |
| Vanguard Group Inc | 580,478 | $6.19M | 0.00% | +5,261+0.9% | Added |
| Artal Group S.A. | 593,030 | $6.33M | 0.16% | 00.0% | Unchanged |
| BVF Inc | 1,589,495 | $17.0M | 0.66% | +1,589,495 | New |
| Frazier Management LLC | 1,771,844 | $18.9M | 1.51% | −799,606−31.1% | Reduced |
| Avidity Partners Management LP | 1,932,000 | $20.6M | 0.53% | +437,000+29.2% | Added |
| Omega Fund Management, LLC | 2,029,580 | $21.7M | 2.43% | +744,680+58.0% | Added |
| OrbiMed Advisors LLC | 4,081,592 | $43.6M | 0.48% | +1,010,637+32.9% | Added |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −300,454−100.0% | Sold out |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −275,169−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −67,156−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −35,523−100.0% | Sold out |
| Hancock Whitney Corp | 0 | $0 | 0.00% | −18,721−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −2,700−100.0% | Sold out |
| Western Wealth Management, LLC | – | – | – | – | Not filed |